Targeting autophagy in pancreatic cancer: The cancer stem cell perspective

Targeting autophagy in pancreatic cancer: The cancer stem cell perspective

Pancreatic cancer is currently the seventh leading cause of cancer-related deaths worldwide, with the estimated death toll approaching half a million annually. Pancreatic ductal adenocarcinoma (PDAC) is the most common (>90% of cases) and most aggressive form of pancreatic cancer, with extrem...

Full description

Bibliographic Details
Main Authors:	Dimitrios Troumpoukis, Adriana Papadimitropoulou, Chrysanthi Charalampous, Paraskevi Kogionou, Kostas Palamaris, Panagiotis Sarantis, Ioannis Serafimidis
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Oncology
Subjects:	autophagy pancreas pancreatic cancer PDAC - pancreatic ductal adenocarcinoma Cancer Stem Cell (CSC) pancreatic cancer stem cells
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1049436/full

Similar Items

Stem Cells in the Exocrine Pancreas during Homeostasis, Injury, and Cancer
by: Sophie C. Lodestijn, et al.
Published: (2021-06-01)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
by: Gitika Thakur, et al.
Published: (2021-02-01)

A Comprehensive Characterization of Stemness in Cell Lines and Primary Cells of Pancreatic Ductal Adenocarcinoma
by: Benedetta Ferrara, et al.
Published: (2022-09-01)

Therapeutic Aspects and Molecular Targets of Autophagy to Control Pancreatic Cancer Management
by: Md. Ataur Rahman, et al.
Published: (2022-06-01)

Current Screening Strategies for Pancreatic Cancer
by: Petr Vanek, et al.
Published: (2022-08-01)

Roles of microbiota in pancreatic cancer development and treatment
by: Mariana Santos Cruz, et al.
Published: (2024-12-01)

Inactivation of APC Induces CD34 Upregulation to Promote Epithelial-Mesenchymal Transition and Cancer Stem Cell Traits in Pancreatic Cancer
by: Mei Jen Hsieh, et al.
Published: (2020-06-01)

Risk prediction of pancreatic cancer using AI analysis of pancreatic subregions in computed tomography images
by: Sehrish Javed, et al.
Published: (2022-11-01)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
by: Natalia Michalak, et al.
Published: (2023-06-01)

Mechanisms of Cancer Cell Death: Therapeutic Implications for Pancreatic Ductal Adenocarcinoma
by: Hannah Pook, et al.
Published: (2021-09-01)

Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
by: Adam S. Bryce, et al.
Published: (2022-10-01)

Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer
by: Lei Zhu, et al.
Published: (2020-05-01)

Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma
by: Chengru Yang, et al.
Published: (2024-01-01)

Crosstalk of nervous and immune systems in pancreatic cancer
by: Fei-Fei Huang, et al.
Published: (2023-11-01)

Pancreatic Cancer Associated Fibroblasts (CAF): Under-Explored Target for Pancreatic Cancer Treatment
by: Jeffrey Norton, et al.
Published: (2020-05-01)

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer
by: Zelin Hou, et al.
Published: (2023-06-01)

Metabolic Adaptation during nab-Paclitaxel Resistance in Pancreatic Cancer Cell Lines
by: Lukas M. Braun, et al.
Published: (2020-05-01)

Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study
by: Karolina Skubisz, et al.
Published: (2023-06-01)

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer
by: Jessica Allen, et al.
Published: (2020-10-01)

Cancer Stem Cells in Pancreatic Cancer
by: Karl-Walter Jauch, et al.
Published: (2010-08-01)

Purinergic Signaling in Pancreas—From Physiology to Therapeutic Strategies in Pancreatic Cancer
by: Ivana Novak, et al.
Published: (2020-11-01)

The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma
by: Ricki T. Krog, et al.
Published: (2021-11-01)

Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition
by: Consuelo Gajate, et al.
Published: (2021-12-01)

Genome-Wide Analysis of lncRNA-mRNA Co-Expression Networks in CD133+/CD44+ Stem-like PDAC Cells
by: Giasemi C. Eptaminitaki, et al.
Published: (2023-02-01)

CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
by: Cristiana Tanase, et al.
Published: (2020-08-01)

Profound Reprogramming towards Stemness in Pancreatic Cancer Cells as Adaptation to AKT Inhibition
by: Hugo Arasanz, et al.
Published: (2020-08-01)

EMT and Stemness—Key Players in Pancreatic Cancer Stem Cells
by: Eva Rodriguez-Aznar, et al.
Published: (2019-08-01)

Current Limitations and Novel Perspectives in Pancreatic Cancer Treatment
by: Steve Robatel, et al.
Published: (2022-02-01)

Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
by: Kostas Palamaris, et al.
Published: (2021-11-01)

Progressively De-Differentiated Pancreatic Cancer Cells Shift from Glycolysis to Oxidative Metabolism and Gain a Quiescent Stem State
by: Giulia Ambrosini, et al.
Published: (2020-06-01)

Epithelial and Mesenchymal-like Pancreatic Cancer Cells Exhibit Different Stem Cell Phenotypes Associated with Different Metastatic Propensities
by: Lisa-Marie Philipp, et al.
Published: (2024-02-01)

Transcriptional Profile of Human Pancreatic Acinar Ductal Metaplasia
by: Jinmai Jiang, et al.
Published: (2023-01-01)

Decoding Metabolic Symbiosis between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts Using Cultured Tumor Microenvironment
by: Yuma Nihashi, et al.
Published: (2023-07-01)

Adjuvant FOLFIRINOX in Patients with Resectable Pancreatic Cancer Is Effective but Rarely Feasible in Real Life: Is Neoadjuvant FOLFIRINOX a Better Option?
by: Yossi Maman, et al.
Published: (2023-06-01)

Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity
by: Quan Zheng, et al.
Published: (2023-11-01)

Pancreatic cancer stemness: dynamic status in malignant progression
by: Yutong Zhao, et al.
Published: (2023-05-01)

Therapeutic Strategies for Pancreatic-Cancer-Related Type 2 Diabetes Centered around Natural Products
by: Moon Nyeo Park
Published: (2023-11-01)

The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: A Review Article for the Latest Guidelines and Novel Therapies
by: Marwa Elsayed, et al.
Published: (2021-04-01)

Management of Metastatic Pancreatic Cancer—Comparison of Global Guidelines over the Last 5 Years
by: Monika Pajewska, et al.
Published: (2023-09-01)

Metastatic Transition of Pancreatic Ductal Cell Adenocarcinoma Is Accompanied by the Emergence of Pro-Invasive Cancer-Associated Fibroblasts
by: Shaofei Liu, et al.
Published: (2022-04-01)